| Description | DCPLA-ME (2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid methyl ester) is the methyl ester form of DCPLA and can be used to treat neurodegenerative diseases. It is an effective PKCε activator. |
| Synonyms | Methyl 8-[2-[(2-pentylcyclopropyl)methyl]cyclopropyl]octanoate, 2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid methyl ester, Methyl 8-(2-((2-pentylcyclopropyl)methyl)cyclopropyl)octanoate, DCPLA methyl ester |
| molecular weight | 322.53 |
| Molecular formula | C21H38O2 |
| CAS | 56687-67-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 1mg/ml, Sonication is recommended. |
| References | 1. Thomas J. Nelson, et al. Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases. WO2015058191A1. |